BioSpace News Archive

Could Augmented Reality Benefit Patient Experience in Managing Healthcare?

More and more biopharma companies are moving toward the use of artificial intelligence and machine learning as they develop therapies for a wide range of diseases.

July 5, 2018
·
2 min read
·
Alex Keown
Job Trends

Another Biotech Company Setups Up Shop in New Jersey

Boston, New York, San Diego and San Francisco are the typical spots that people refer to when they think about biotech hotspots in the United States. But don’t discount New Jersey.

July 5, 2018
·
2 min read
·
Alex Keown
Business

Martin Shkreli Speaks from Prison About the Biopharma Industry

Martin Shkreli has been blogging about the biopharma industry from prison.

July 5, 2018
·
2 min read
·
Alex Keown
Drug Development

Merz Snags FDA Approval for Chronic Drooling Treatment

Merz Neurosciences announced that the U.S. Food and Drug Administration approved a treatment for chronic drooling in adults.

July 5, 2018
·
2 min read
·
Alex Keown
Policy

LADAVRU® NEWS “HOVERINK BIOTECHNOLOGIES SEEKS COMMERCIAL PARTNERING OPPORTUNITIES IN ONCOLOGY SUPPORTIVE THERAPIES AND SEEKS A COMMERCIALIZATION AGREEMENT FOR ITS INVESTIGATIONAL DRUG LADAVRU®”

HOVERINK BIOTECHNOLOGIES, seeks to enter into a licensing agreement for the exclusive rights to commercialize LADAVRU(TM) (Dronabinol for injection) and an oral formulation of LADAVRU®.

July 5, 2018
·
5 min read
Deals

Xtant Medical Holdings, Inc. Announces Expiration of Rights Offering

XtantTM Medical Holdings, Inc. announces that the subscription period for its previously announced rights offering of shares of the Company’s common stock at a subscription price of $7.20 per share expired on June 18, 2018, and these rights are no longer exercisable.

July 5, 2018
·
4 min read
Business

Devonian Announces the Signing of a Non-Binding Letter of Intent with Folia Biotech to develop FB-631 in cancer immunotherapy

Devonian Health Group Inc. and Folia Biotech inc. announce the signing of a non-binding Letter of Intent (‘‘LOI’’) to exclusively negotiate the terms establishing an immune-oncology strategic collaboration focused on the development of FB-631 as an immunotherapeutic platform.

July 5, 2018
·
5 min read
Pharm Country

Konica Minolta Launches Portable Ultrasound with One-touch Image Optimization for Improved Workflow and Diagnostic Efficiency

Konica Minolta Healthcare Americas, Inc., announces the introduction of the SONIMAGE® MX1 portable ultrasound system

July 5, 2018
·
3 min read
Business

RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®

RedHill has been grantedthe exclusive right to co-promote Mytesi® (crofelemer 125 mg delayed-release tablets) in the U.S. to certain gastroenterologists and primary care physicians for the approved indication in people living with HIV/AIDS by Napo Pharmaceuticals, a subsidiary of Jaguar Health

July 5, 2018
·
10 min read
Deals

Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offerings in the U.S.

Novacap announced today that it has completed the acquisition of PCI Synthesis.

July 5, 2018
·
3 min read